Lung cancer patients could especially benefit from new ‘QTA’ techniqueContinue reading→

The 2014 BIO International Convention, where the global biotech community meets, connecting the people, companies and innovations that help to fulfill the promise of biotechnology through healing, fueling, and feeding the world, concluded today at the San Diego Convention Center with a record number of partnering meetings. Hosted by the Biotechnology Industry Organization (BIO), the event drew 15,667 industry leaders, including nearly 2,500 CEO’s, from 50 states and 70 countries.Continue reading→

Provant Therapy Mechanism of Action Video Animation Now Available

Life science laboratory research shows Provant treats pain two ways

Scottsdale, Arizona, June 27, 2014 — Regenesis Biomedical Inc., today announced the release of an animation on the Provant Therapy System’s mechanism of action. This video shows how Provant treats pain two ways: anti-nociceptive analgesia, and anti-inflammatory.

Pain management and the treatment of inflammation are important considerations following operative procedures. Persistent pain may lead to reduced physical function and sense of well-being, increased consumption of opioid analgesics, and expensive, invasive ancillary procedures (including hospital readmissions, repeat surgeries, extended physical therapy, lab tests, radiology, epidural injections, and implantation of spinal cord stimulators and intrathecal drug pumps).

“Post-op pain is often undermanaged, and narcotic use continues to rise,” said Scott Brooks, President and Chief Executive Officer of Regenesis Biomedical. “Regenesis’ life science research further validates the pain relief effect seen in Provant patients. As an alternative treatment, Provant may allow patients to avoid expensive procedures, reduce opioid consumption, and avoid opioid negative side effects.”

The video may be viewed at http://www.regenesisbio.com/our-videos.php

About Regenesis Biomedical

Regenesis Biomedical, Inc. is a privately held medical technology company focused on the research, design, manufacture, and sale of energy-based medical products and services that alleviate pain, restore health, and improve quality of life. Regenesis developed, patented, and now markets the Provant Therapy System. Our customers include health care facilities and providers that serve patients treated in acute care hospitals, long-term care, outpatient clinics, and home care.

About the Provant®

Therapy System Provant uses pulsed electromagnetic energy to facilitate reduction of the pain and edema associated with post-operative, superficial soft tissues. Provant relieves pain two ways: through anti-nociceptive analgesia by inducing endogenous opioids, and by regulating inflammatory mediators.

Contact: Regenesis Biomedical, Inc.

Scott Robey, Vice President Marketing

www.regenesisbio.com

480-970-4970 phone

SOURCE: Regenesis Biomedical Inc.

Six early-stage companies, including two life science companies, were announced winners Wednesday in the Arizona Commerce Authority’s Spring 2014 Arizona Innovation Challenge.Continue reading→